These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10491870)

  • 21. Risk factors for hepatitis B in an outbreak of hepatitis B and D among injection drug users.
    Bialek SR; Bower WA; Mottram K; Purchase D; Nakano T; Nainan O; Williams IT; Bell BP
    J Urban Health; 2005 Sep; 82(3):468-78. PubMed ID: 16049202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of hepatitis B, tetanus, hepatitis A, human immunodeficiency virus and feasibility of vaccine delivery among injecting drug users in Bangkok, Thailand, 2003-2005.
    Sunthornchart S; Linkins RW; Natephisarnwanish V; Levine WC; Maneesinthu K; Lolekha R; Tappero JW; Trirat N; Muktier S; Chancharastong P; Fox K; Donchalermpak S; Vitek C; Supawitkul S
    Addiction; 2008 Oct; 103(10):1687-95. PubMed ID: 18705685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changing serological status and low vaccination-induced protection rates against hepatitis B characterize chronic hepatitis C virus-infected injecting drug users in Greece: need for immunization policy.
    Elefsiniotis IS; Pantazis KD; Ketikoglou ID; Koutsounas SI; Tsianos EV
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1227-31. PubMed ID: 17033445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Past infection with hepatitis A virus among Vancouver street youth, injection drug users and men who have sex with men: implications for vaccination programs.
    Ochnio JJ; Patrick D; Ho M; Talling DN; Dobson SR
    CMAJ; 2001 Aug; 165(3):293-7. PubMed ID: 11517645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knowledge of hepatitis among active drug injectors at a syringe exchange program.
    Carey J; Perlman DC; Friedmann P; Kaplan WM; Nugent A; Deutscher M; Masson CL; Des Jarlais DC
    J Subst Abuse Treat; 2005 Jul; 29(1):47-53. PubMed ID: 15979531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sudden rise in uptake of hepatitis B vaccination among injecting drug users associated with a universal vaccine programme in prisons.
    Hutchinson SJ; Wadd S; Taylor A; Bird SM; Mitchell A; Morrison DS; Ahmed S; Goldberg DJ
    Vaccine; 2004 Nov; 23(2):210-4. PubMed ID: 15531039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
    Maher L; Chant K; Jalaludin B; Sargent P
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population-based prevalence of hepatitis B and C virus, HIV, syphilis, gonorrhoea and chlamydia in male injection drug users in Lagos, Nigeria.
    Tun W; Vu L; Adebajo SB; Abiodun L; Sheehy M; Karlyn A; Njab J; Ahonsi B; Issa BK; Idogho O
    Int J STD AIDS; 2013 Aug; 24(8):619-25. PubMed ID: 23970571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The outcome of a rapid hepatitis B vaccination programme in a methadone treatment clinic.
    Ramasamy P; Lintzeris N; Sutton Y; Taylor H; Day CA; Haber PS
    Addiction; 2010 Feb; 105(2):329-34. PubMed ID: 20078489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS; Brajachand N; Singh HL; Singh YM
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poor validity of self-reported hepatitis B virus infection and vaccination status among young drug users.
    Kuo I; Mudrick DW; Strathdee SA; Thomas DL; Sherman SG
    Clin Infect Dis; 2004 Feb; 38(4):587-90. PubMed ID: 14765355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decline in hepatitis B infection observed after 11 years of regional vaccination among Danish drug users.
    Mössner BK; Skamling M; Jørgensen TR; Georgsen J; Pedersen C; Christensen PB
    J Med Virol; 2010 Oct; 82(10):1635-9. PubMed ID: 20827758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors associated with hepatitis B vaccine series completion in a randomized trial for injection drug users reached through syringe exchange programs in three US cities.
    Bowman S; Grau LE; Singer M; Scott G; Heimer R
    BMC Public Health; 2014 Aug; 14():820. PubMed ID: 25107530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gender differences in hepatitis C seroprevalence and suboptimal vaccination and hepatology services uptake amongst substance misusers.
    Marufu M; Williams H; Hill SL; Tibble J; Verma S
    J Med Virol; 2012 Nov; 84(11):1737-43. PubMed ID: 22997076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An outbreak of acute hepatitis B infection among injecting drug users in Inverclyde, Scotland.
    Stevenson J; Tannahill M; Biggs V
    Commun Dis Public Health; 2001 Mar; 4(1):60-3. PubMed ID: 11467023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serologic examination of hepatitis B infection and immunization in HIV-positive youth and associated risks. The Pediatric AIDS Clinical Trials Group Protocol 220 Team.
    Rogers AS; Lindsey JC; Futterman DC; Zimmer B; Abdalian SE; D'Angelo LJ
    AIDS Patient Care STDS; 2000 Dec; 14(12):651-7. PubMed ID: 11119432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential of specialist drug services to deliver hepatitis B vaccination.
    Morrison DS; Gilchrist G; Ahmed S
    Commun Dis Public Health; 2002 Dec; 5(4):321-3. PubMed ID: 12564250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The significance of the isolated anti-HBc carrier. A study of 1797 drug addicts. The Intersert Group of Scientific Collaboration].
    Mezzelani P; Quaglio G; Venturini L; Lugoboni F
    Recenti Prog Med; 1994 Sep; 85(9):419-24. PubMed ID: 7938872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: findings from a population size estimation and respondent driven sampling survey.
    Johnston L; Saumtally A; Corceal S; Mahadoo I; Oodally F
    Int J Drug Policy; 2011 Jul; 22(4):252-8. PubMed ID: 21700442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies.
    Gandhi RT; Wurcel A; Lee H; McGovern B; Shopis J; Geary M; Sivamurthy R; Sax PE; Ukomadu C
    J Infect Dis; 2005 May; 191(9):1435-41. PubMed ID: 15809901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.